CLEVELAND BIOLABS INC Contracts & Agreements

Assignment of Promissory Note, dated November 7, 2022, by and among Avenue Venture Opportunities Fund, L.P., Silverback Capital Corporation and Statera Biopharma, Inc (Filed With SEC on November 15, 2022)

Amended and Restated Convertible Note Due May 1, 2024, dated as of November 7, 2022 (Filed With SEC on November 15, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on November 7, 2022)

Form of Securities Purchase Agreement by and between the Company and the purchasers named therein (Filed With SEC on November 7, 2022)

Warrant Agency Agreement dated March 24, 2022 (Filed With SEC on October 28, 2022)

Assignment of Promissory Note, dated October 18, 2022, by and among Avenue Venture Opportunities Fund, L.P., Silverback Capital Corporation and Statera Biopharma, Inc (Filed With SEC on October 24, 2022)

Amended and Restated Convertible Note Due May 1, 2024, dated as of October 18, 2022 (Filed With SEC on October 24, 2022)

Warrant Agency Agreement, dated as of March 24, 2022, by and between the Company and Continental Stock Transfer & Trust Company, LLC (Filed With SEC on October 21, 2022)

Memorandum of Understanding, dated October 12, 2022, between Statera Biopharma, Inc. and Holobeam Technologies, Inc (Filed With SEC on October 17, 2022)

Binding Letter of Intent, dated September 2, 2022, by and between Statera Biopharma, Inc. and Lay Sciences, Inc (Filed With SEC on September 9, 2022)

Form of Independent Directors Agreement (Filed With SEC on June 22, 2022)

Forbearance and Second Amendment to Loan Documents, dated April 18, 2022 (Filed With SEC on May 27, 2022)

Form of Underwriting Agreement, dated March 22, 2022, by and between Statera Biopharma, Inc. and EF Hutton, a division of Benchmark Investments, LLC (Filed With SEC on March 25, 2022)

Form of One Year Common Stock Purchase Warrant (Filed With SEC on March 25, 2022)

Form of Five Year Common Stock Purchase Warrant (Filed With SEC on March 25, 2022)

Form of Form of Pre-funded Warrant (Filed With SEC on March 25, 2022)

Form of Waiver (Filed With SEC on March 22, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on February 7, 2022)

Form of Securities Purchase Agreement, dated February 6, 2022, by and between Statera Biopharma, Inc. and the investor party thereto (Filed With SEC on February 7, 2022)

Placement Agency Agreement, dated February 6, 2021, by and between Statera Biopharma, Inc. and EF Hutton, a division of Benchmark Investments, LLC (Filed With SEC on February 7, 2022)

Loan and Security Agreement, dated as of April 26, 2021, by and among Cytocom, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 2, 2021)

Supplement to the Loan and Security Agreement dated as of April 26, 2021 between Cytocom, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 2, 2021)

Warrant to Purchase Shares of Common Stock of Cytocom Inc., dated as of July 27, 2021, issued to Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 2, 2021)

Amended and Restated Share Purchase Agreement, dated as of July 27, 2021, by and among GEM Global Yield LLC SCS, GEM Yield Bahamas Limited and Cytocom Inc (Filed With SEC on August 2, 2021)

Warrant to Purchase Shares of Cytocom Inc., dated as of July 27, 2021, issued to GEM Yield Bahamas Limited (Filed With SEC on August 2, 2021)

Form of 2021 Warrants (Filed With SEC on August 2, 2021)

Amended and Restated Registration Rights Agreement, dated as of July 27, 2021, by and among GEM Global Yield LLC SCS, GEM Yield Bahamas Limited and Cytocom Inc (Filed With SEC on August 2, 2021)

Executive Employment Agreement, dated as of August 19, 2020, as amended, by and among Cytocom Inc. and Michael K. Handley (Filed With SEC on July 28, 2021)

Amendment No. 1 to Executive Employment Agreement, dated as of September 6, 2020, by and among Cytocom Inc. and Michael K. Handley (Filed With SEC on July 28, 2021)

Amendment No. 2 to Executive Employment Agreement, dated as of October 31, 2020, by and among Cytocom Inc. and Michael K. Handley (Filed With SEC on July 28, 2021)

Executive Employment Agreement, dated as of October 30, 2020, as amended, by and among Cytocom Inc. and Taunia Markvicka (Filed With SEC on July 28, 2021)

Amendment No. 1 to Executive Employment Agreement, dated as of March 8, 2021, by and among Cytocom Inc. and Taunia Markvicka (Filed With SEC on July 28, 2021)

Executive Employment Agreement, dated as of August 17, 2020, as amended, by and among Cytocom Inc. and Peter Aronstam (Filed With SEC on July 28, 2021)

Amendment No. 1 to Executive Employment Agreement, dated as of September 6, 2020, by and among Cytocom Inc. and Peter Aronstam (Filed With SEC on July 28, 2021)

Amendment No. 2 to Executive Employment Agreement, dated as of October 31, 2020, by and among Cytocom Inc. and Peter Aronstam (Filed With SEC on July 28, 2021)

Form of Placement Agent Warrant (Filed With SEC on February 23, 2021)

Form of Securities Purchase Agreement, dated as of February 19, 2021, between Cleveland BioLabs, Inc. and the purchasers named therein (Filed With SEC on February 23, 2021)

Award/Contract W81XWH-15-0101 modification dated September 29, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on November 16, 2020)

Award/Contract W81XWH-15-0570 modification dated September 29, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on November 16, 2020)

Merger Agreement, dated as of October 16, 2020, between Cleveland Biolabs, Inc., High Street Acquisition Corp. and Cytocom, Inc (Filed With SEC on October 19, 2020)

Form of Voting and Support Agreement (Filed With SEC on October 19, 2020)

Consulting Agreement, dated as of October 11, 2020, between Cleveland BioLabs, Inc. and Andrei Gudkov, , Ph.D., D. Sci (Filed With SEC on October 13, 2020)

Settlement and General Release Agreement, dated as of July 15, 2020, between Cleveland BioLabs, Inc. and Alpha Capital Anstalt (Filed With SEC on August 14, 2020)

Award/Contract W81XWH-15-0570 modification dated July 31, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on August 14, 2020)

Consulting Agreement, dated as of August 10, 2020, between Cleveland BioLabs, Inc. and Sound Clinical Solutions, SP (Filed With SEC on August 14, 2020)

Award/Contract W81XWH-15-0101 modification dated July 31, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on July 31, 2020)

Form of Warrant (Filed With SEC on June 3, 2020)

Form of Placement Agent Warrant (Filed With SEC on June 3, 2020)

Form of Securities Purchase Agreement, dated as of June 1, 2020, between Cleveland BioLabs, Inc. and the purchasers named therein (Filed With SEC on June 3, 2020)

Description of Registrant's Securities (Filed With SEC on April 15, 2020)

Award/Contract W81XWH-15-0101 modification dated March 18, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on April 15, 2020)

Award/Contract W81XWH-15-C-0101 modification dated February 28, 2019 issued by USA Med Research ACQ Activity (Filed With SEC on May 15, 2019)

Simple Agreement for Future Equity, dated as of August 10, 2018, among Genome Protection, Inc., Norma Investments Limited, Cleveland BioLabs, Inc. and Everon Biosciences, Inc (Filed With SEC on August 14, 2018)

Director Designation Agreement, dated as of August 10, 2018, among Genome Protection, Inc., Everon Biosciences, Inc., Cleveland BioLabs, Inc. and Norma Investments Limited (Filed With SEC on August 14, 2018)

License Agreement, dated as of August 6, 2018, between Cleveland BioLabs, Inc. and Genome Protection, Inc (Filed With SEC on August 10, 2018)

Assignment Agreement, dated as of August 6, 2018, between Cleveland BioLabs, Inc. and Genome Protection, Inc (Filed With SEC on August 10, 2018)

Cleveland BioLabs, Inc. Equity Incentive Plan (Filed With SEC on May 1, 2018)

Award/Contract W81XWH-15-C-0101 modification dated September 14, 2017 issued by USA Med Research ACQ Activity (Filed With SEC on November 14, 2017)

SEPARATION AND CONSULTING AGREEMENT (Filed With SEC on May 6, 2016)

STOCKSUBSCRIPTION AGREEMENT (Filed With SEC on December 24, 2015)

ACKNOWLEDGMENTAGREEMENT (Filed With SEC on December 24, 2015)

Title (Filed With SEC on November 9, 2015)

U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND (USAMRMC) U. S. ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY (USAMRAA) TERMS AND CONDITIONS FOR ASSISTANCE AGREEMENTS WITH FOR-PROFIT... (Filed With SEC on November 9, 2015)

EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on July 10, 2015)

EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on July 10, 2015)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 10, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 24, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 24, 2015)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 11, 2015)

MASTERPURCHASE AGREEMENT (Filed With SEC on May 4, 2015)

OPTION AGREEMENT (Filed With SEC on May 4, 2015)

ROYALTYAGREEMENT (Filed With SEC on May 4, 2015)

THIRD AMENDMENT TO CLEVELAND BIOLABS, INC. EQUITY INCENTIVE PLAN (Filed With SEC on April 17, 2015)

FIRST AMENDMENT TO 2013 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on April 17, 2015)

AMENDMENT TO CONSULTINGAGREEMENT (Filed With SEC on February 27, 2015)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on February 9, 2015)

SERIES B PREFUNDED COMMON STOCK PURCHASE WARRANT CLEVELAND BIOLABS, INC. (Filed With SEC on February 9, 2015)

SERIES A COMMON STOCKPURCHASE WARRANT CLEVELAND BIOLABS, INC. (Filed With SEC on February 9, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 9, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 9, 2015)

AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT AND MARCH 2010 WARRANTS (Filed With SEC on January 13, 2015)

AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT AND SERIES D WARRANTS (Filed With SEC on October 2, 2014)

AMENDMENT TO SERIES A COMMON STOCK PURCHASE WARRANT (Filed With SEC on September 8, 2014)

AMENDMENT No. 1 TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 8, 2014)

SECOND AMENDMENT TO PARTICIPATION AGREEMENT (Filed With SEC on August 11, 2014)

THIRD AMENDMENT TO PARTICIPATION AGREEMENT (Filed With SEC on August 6, 2014)

WARRANT AGREEMENT ToPurchase Shares of the Common Stock of Cleveland BioLabs, Inc. (Filed With SEC on June 20, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 20, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 20, 2014)

RIGHTS AGREEMENT (Filed With SEC on June 20, 2014)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 20, 2014)

CLEVELAND BIOLABS, INC. SEVERANCE BENEFIT PLAN (Filed With SEC on May 13, 2014)

AMENDMENT NO. 1 TO INVESTMENT AGREEMENT OF PANACELA LABS, INC. (Filed With SEC on March 17, 2014)

Cleveland BioLabs, Inc. Annual Executive Bonus Plan (Filed With SEC on March 17, 2014)

[SERIES A/B] COMMON STOCK PURCHASE WARRANT CLEVELAND BIOLABS, INC. (Filed With SEC on January 15, 2014)

430 Park Avenue | NewYork, New York 10022 | 212 ###-###-#### | www.hcwco.com Member: FINRA/SIPC (Filed With SEC on January 15, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 15, 2014)

WARRANT AGREEMENT To Purchase Shares of the Common Stock of Cleveland BioLabs, Inc. Dated as of September 30, 2013 (the Effective Date) (Filed With SEC on November 8, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on November 8, 2013)

Master Services Agreement (Filed With SEC on October 18, 2013)

Warrant Number: H-1Issue Date: September 3, 2013 CLEVELAND BIOLABS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 5, 2013)

MASTER AGREEMENT (Filed With SEC on September 5, 2013)

EXECUTION COPY/$,/ !/ (Filed With SEC on September 5, 2013)

Cleveland BioLabs, Inc. 2013 Employee Stock Purchase Plan Adopted by the Board of Directors: May 7,2013 Approved by the Stockholders: June 14,2013 (Filed With SEC on June 20, 2013)

CLEVELAND BIOLABS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 9, 2013)

ClevelandBioLabs, Inc. 7,500,000 Shares of Common Stock Warrants to Purchase 3,750,000 Sharesof Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 22, 2012)

WARRANT AGREEMENT (Filed With SEC on October 22, 2012)

CBLI Long-term Executive Compensation Incentive Plan (Filed With SEC on June 15, 2012)

Cleveland BioLabs, Inc. 2012 Executive Compensation Plan (Filed With SEC on April 30, 2012)

Cleveland BioLabs, Inc. 2012 Executive Compensation Plan (Filed With SEC on April 18, 2012)

INVESTMENT AGREEMENT (Filed With SEC on November 9, 2011)

EXCLUSIVE LICENSE AND OPTION AGREEMENT (Filed With SEC on November 9, 2011)

SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 9, 2011)

EXCLUSIVE LICENSE AND OPTION AGREEMENT (Filed With SEC on November 9, 2011)

AMENDED AND RESTATED EXCLUSIVE SUBLICENSE AGREEMENT (Filed With SEC on November 9, 2011)

EXCLUSIVE SUBLICENSE AGREEMENT (Filed With SEC on November 9, 2011)

ASSIGNMENT AGREEMENT (Filed With SEC on November 9, 2011)

CLEVELAND BIOLABS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2011)

AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 4, 2011)

Statement of Work (Filed With SEC on June 29, 2011)

Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on June 21, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 21, 2011)

CONSULTING AGREEMENT (Filed With SEC on June 13, 2011)

FIRST AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on June 13, 2011)

1,400,000Shares of Common Stock (Filed With SEC on December 29, 2010)

FORM OFSUBSCRIPTION AGREEMENT (Filed With SEC on December 29, 2010)

FORMOF AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 29, 2010)

FIRSTAMENDMENT TO PARTICIPATION AGREEMENT (Filed With SEC on August 16, 2010)

COMMONSTOCK PURCHASE WARRANT CLEVELANDBIOLABS, INC. Warrant Shares: ______ Initial Issue Date: March 2, 2010 (Filed With SEC on February 26, 2010)

COMMONSTOCK PURCHASE WARRANT CLEVELANDBIOLABS, INC. Warrant Shares: ______ Initial Issue Date: March __, 2010 (Filed With SEC on February 26, 2010)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 26, 2010)

PARTICIPATIONAGREEMENT (Filed With SEC on January 5, 2010)

LICENSEAGREEMENT (Filed With SEC on September 9, 2009)

ClevelandBioLabs, Inc. 73High Street Buffalo,New York 14203 (Filed With SEC on March 30, 2009)

COMMONSTOCK PURCHASE WARRANT CLEVELANDBIOLABS, INC. (Filed With SEC on March 30, 2009)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 30, 2009)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on March 30, 2009)

VOTINGAGREEMENT (Filed With SEC on March 30, 2009)

AMENDMENT AND WAIVERAGREEMENT (Filed With SEC on March 30, 2009)

AMENDMENTAND REAFFIRMATION AGREEMENT (Filed With SEC on March 30, 2009)

Exhibit 10.1 CLEVELAND BIOLABS, INC. EQUITY INCENTIVE PLAN (as amended and restated effective April 29, 2008) CLEVELAND BIOLABS, INC. EQUITY INCENTIVE PLAN (Filed With SEC on April 30, 2008)

[FORM OF SERIES B WARRANT] (Filed With SEC on March 19, 2007)

[FORM OF SERIES C WARRANT] (Filed With SEC on March 19, 2007)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 19, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 19, 2007)

VOTING AGREEMENT (Filed With SEC on March 19, 2007)

SPONSORED RESEARCH AGREEMENT (Filed With SEC on January 12, 2007)

Category

Industry

Companies

Contracts

CLEVELAND BIOLABS INC Contracts & Agreements